Nymox Pharmaceutical Corporation NYMX

$ 0.2 -19.68%

Annual report 2022
added 11-09-2024

Nymox Pharmaceutical Corporation EV/EBITDA Ratio 2011-2024 | NYMX

Annual EV/EBITDA Ratio Nymox Pharmaceutical Corporation

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-6.65	-15.1	-20.5	-11.1	-13.2	-10.5	-4.92	-2.93	-39.9	-29	-26.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.93	-39.9	-16.4